Our poster today at #SMDM23 wherein we discuss some of the nuances about selecting potential therapeutic alternatives when negotiating prices of selected drugs under the #IRA.
#PORTAL_research #healthecon #exonsky
#PORTAL_research #healthecon #exonsky
October 23, 2023 at 11:59 AM
Our poster today at #SMDM23 wherein we discuss some of the nuances about selecting potential therapeutic alternatives when negotiating prices of selected drugs under the #IRA.
#PORTAL_research #healthecon #exonsky
#PORTAL_research #healthecon #exonsky
Terrific flute solo from @HMSbioethics graduate @Beatrice__Brown to close out the @HarvardMed MBE graduation ceremony.
I look forward to working with you @PORTAL_Research @BrighamResearch, Bea! #WeAreHarvard #HarvardMed2020
I look forward to working with you @PORTAL_Research @BrighamResearch, Bea! #WeAreHarvard #HarvardMed2020
November 18, 2024 at 9:47 AM
Terrific flute solo from @HMSbioethics graduate @Beatrice__Brown to close out the @HarvardMed MBE graduation ceremony.
I look forward to working with you @PORTAL_Research @BrighamResearch, Bea! #WeAreHarvard #HarvardMed2020
I look forward to working with you @PORTAL_Research @BrighamResearch, Bea! #WeAreHarvard #HarvardMed2020
NEW @NEJM @NEJMPerspec with @weparmet @NUSL @NUSLHealth:
#COVID19 — The Law and Limits of Quarantine
cc: @HarvardMIT_CRS @HiTSatHarvard @HMSbioethics @PORTAL_Research
#COVID19 — The Law and Limits of Quarantine
cc: @HarvardMIT_CRS @HiTSatHarvard @HMSbioethics @PORTAL_Research
November 18, 2024 at 9:46 AM
NEW @NEJM @NEJMPerspec with @weparmet @NUSL @NUSLHealth:
#COVID19 — The Law and Limits of Quarantine
cc: @HarvardMIT_CRS @HiTSatHarvard @HMSbioethics @PORTAL_Research
#COVID19 — The Law and Limits of Quarantine
cc: @HarvardMIT_CRS @HiTSatHarvard @HMSbioethics @PORTAL_Research
.@ASLMENews made it all the way to #BuenosAires #Argentina! It may have also been spotted in #Santiago #Chile last weekend. cc: @ehutch01 @aslme_events @PORTAL_Research @akesselheim @HarvardMIT_CRS @harvardmed @HMSbioethics @NUSLHealth @LeoBeletsky @weparmet #HLP2019 #HLP2020
November 18, 2024 at 9:44 AM
.@ASLMENews made it all the way to #BuenosAires #Argentina! It may have also been spotted in #Santiago #Chile last weekend. cc: @ehutch01 @aslme_events @PORTAL_Research @akesselheim @HarvardMIT_CRS @harvardmed @HMSbioethics @NUSLHealth @LeoBeletsky @weparmet #HLP2019 #HLP2020
NEW publication in @JournalGIM led by @PORTAL_Research colleague Emily H. Jung:
@US_FDA and @EMA_News #Biosimilar Approvals:
@US_FDA and @EMA_News #Biosimilar Approvals:
November 18, 2024 at 9:42 AM
NEW publication in @JournalGIM led by @PORTAL_Research colleague Emily H. Jung:
@US_FDA and @EMA_News #Biosimilar Approvals:
@US_FDA and @EMA_News #Biosimilar Approvals:
NEW publication in @MayoProceedings led by @PORTAL_Research colleague and @HarvardMed student Thomas J. Hwang:
Prescription Opioid Epidemic and Trends in the Clinical Development of New Pain Medications
Prescription Opioid Epidemic and Trends in the Clinical Development of New Pain Medications
November 18, 2024 at 9:42 AM
NEW publication in @MayoProceedings led by @PORTAL_Research colleague and @HarvardMed student Thomas J. Hwang:
Prescription Opioid Epidemic and Trends in the Clinical Development of New Pain Medications
Prescription Opioid Epidemic and Trends in the Clinical Development of New Pain Medications
Looking forward to having my advisor and mentor @akesselheim @PORTAL_Research @harvardmed join us at #NUSLDrugLaw for a conversation on pharmaceutical pricing!
cc: @HarvardMIT_CRS @NUSLHealth
cc: @HarvardMIT_CRS @NUSLHealth
November 18, 2024 at 9:40 AM
Looking forward to having my advisor and mentor @akesselheim @PORTAL_Research @harvardmed join us at #NUSLDrugLaw for a conversation on pharmaceutical pricing!
cc: @HarvardMIT_CRS @NUSLHealth
cc: @HarvardMIT_CRS @NUSLHealth
Looking forward to having @PORTAL_Research @AmeetSarpatwari join us for class #NUSLDrugLaw today to discuss biologics and biosimilars!
His recent article on the topic can be found here:
His recent article on the topic can be found here:
November 18, 2024 at 9:39 AM
Looking forward to having @PORTAL_Research @AmeetSarpatwari join us for class #NUSLDrugLaw today to discuss biologics and biosimilars!
His recent article on the topic can be found here:
His recent article on the topic can be found here:
.@PORTAL_Research Director @akesselheim highlights factors that exacerbate antimicrobial resistance: pharmaceutical marketing, patient demand, reimbursement/financing, subtherapeutic animal uses, and a shrinking new drug pipeline #CeBIL2019 @CeBIL_Center
November 18, 2024 at 9:39 AM
.@PORTAL_Research Director @akesselheim highlights factors that exacerbate antimicrobial resistance: pharmaceutical marketing, patient demand, reimbursement/financing, subtherapeutic animal uses, and a shrinking new drug pipeline #CeBIL2019 @CeBIL_Center
My newest law article with @frazer_tessema & @akesselheim @PORTAL_Research (pre-publication, accepted at @HastingsLJ) is now up on @SSRN
View the abstract and download here:
View the abstract and download here:
November 18, 2024 at 9:38 AM
My newest law article with @frazer_tessema & @akesselheim @PORTAL_Research (pre-publication, accepted at @HastingsLJ) is now up on @SSRN
View the abstract and download here:
View the abstract and download here:
#HLP19 #HealthLawRocks I'm speaking next in room 1102 on New Developments in Pharmaceutical Antitrust Law -- will be a 10,000-foot view of the field in 15 minutes -- would take hours to flush out all the nuances! cc: @profmikecarrier @akesselheim @PORTAL_Research @HarvardMIT_CRS
November 18, 2024 at 9:34 AM
#HLP19 #HealthLawRocks I'm speaking next in room 1102 on New Developments in Pharmaceutical Antitrust Law -- will be a 10,000-foot view of the field in 15 minutes -- would take hours to flush out all the nuances! cc: @profmikecarrier @akesselheim @PORTAL_Research @HarvardMIT_CRS
Opening panel at @ASLMENews #HLP19 @LoyolaLaw #HealthLawRocks: Preparing Practice-Ready Health Law Attorneys
cc: @abahealthlaw @healthlawyers @HealthAUWCL @HLPI_UHLC @PORTAL_Research @PetrieFlom @ehutch01 @aslme_events @iuhealthlaw @CLER_BUSPH @GSU_HealthLaw @NUSLHealth
cc: @abahealthlaw @healthlawyers @HealthAUWCL @HLPI_UHLC @PORTAL_Research @PetrieFlom @ehutch01 @aslme_events @iuhealthlaw @CLER_BUSPH @GSU_HealthLaw @NUSLHealth
November 18, 2024 at 9:33 AM
Opening panel at @ASLMENews #HLP19 @LoyolaLaw #HealthLawRocks: Preparing Practice-Ready Health Law Attorneys
cc: @abahealthlaw @healthlawyers @HealthAUWCL @HLPI_UHLC @PORTAL_Research @PetrieFlom @ehutch01 @aslme_events @iuhealthlaw @CLER_BUSPH @GSU_HealthLaw @NUSLHealth
cc: @abahealthlaw @healthlawyers @HealthAUWCL @HLPI_UHLC @PORTAL_Research @PetrieFlom @ehutch01 @aslme_events @iuhealthlaw @CLER_BUSPH @GSU_HealthLaw @NUSLHealth
A privilege to serve as reviewer #3 for @JAMA_current and @JAMAInternalMed in 2018. Look forward to reviewing more great manuscripts in 2019! cc: @PORTAL_Research @HarvardMIT_CRS @HiTSatHarvard
JAMA list:
JAMA IM list:
JAMA list:
JAMA IM list:
November 18, 2024 at 9:29 AM
A privilege to serve as reviewer #3 for @JAMA_current and @JAMAInternalMed in 2018. Look forward to reviewing more great manuscripts in 2019! cc: @PORTAL_Research @HarvardMIT_CRS @HiTSatHarvard
JAMA list:
JAMA IM list:
JAMA list:
JAMA IM list:
.@OversightDems @GOPoversight @SenFinance:
For more on drug pricing, see my @ASLMENews "Health Policy Portal" article with @akesselheim @PORTAL_Research on the impact of the Tax Cuts and Jobs Act of 2017 on the pharmaceutical industry.
Article here:
For more on drug pricing, see my @ASLMENews "Health Policy Portal" article with @akesselheim @PORTAL_Research on the impact of the Tax Cuts and Jobs Act of 2017 on the pharmaceutical industry.
Article here:
November 18, 2024 at 9:27 AM
.@OversightDems @GOPoversight @SenFinance:
For more on drug pricing, see my @ASLMENews "Health Policy Portal" article with @akesselheim @PORTAL_Research on the impact of the Tax Cuts and Jobs Act of 2017 on the pharmaceutical industry.
Article here:
For more on drug pricing, see my @ASLMENews "Health Policy Portal" article with @akesselheim @PORTAL_Research on the impact of the Tax Cuts and Jobs Act of 2017 on the pharmaceutical industry.
Article here:
.@SenateFinance Committee:
Take a look at our @PORTAL_Research @JAMAInternalMed article on @US_FDA's pediatric exclusivity program. Six-month #patent extensions for pediatric research contribute to high #drugprices, particularly for blockbuster drugs
Take a look at our @PORTAL_Research @JAMAInternalMed article on @US_FDA's pediatric exclusivity program. Six-month #patent extensions for pediatric research contribute to high #drugprices, particularly for blockbuster drugs
November 18, 2024 at 9:27 AM
.@SenateFinance Committee:
Take a look at our @PORTAL_Research @JAMAInternalMed article on @US_FDA's pediatric exclusivity program. Six-month #patent extensions for pediatric research contribute to high #drugprices, particularly for blockbuster drugs
Take a look at our @PORTAL_Research @JAMAInternalMed article on @US_FDA's pediatric exclusivity program. Six-month #patent extensions for pediatric research contribute to high #drugprices, particularly for blockbuster drugs
Nice to have @DrBenBearnot @MassGeneralMDs @MGHMedicine join us at @BrighamResearch @harvardmed @PORTAL_Research for a discussion on "Meeting People Who Use Drugs Where They Are" cc: @WeAreAllies_
November 18, 2024 at 9:26 AM
Nice to have @DrBenBearnot @MassGeneralMDs @MGHMedicine join us at @BrighamResearch @harvardmed @PORTAL_Research for a discussion on "Meeting People Who Use Drugs Where They Are" cc: @WeAreAllies_
#policyethx Dr. Steven Pearson @icer_review addresses the burning question: "Why are we here today?" cc: @AmeetSarpatwari @PORTAL_Research @JasonComander @MassEyeAndEar @HMSbioethics @PetrieFlom
November 18, 2024 at 9:26 AM
#policyethx Dr. Steven Pearson @icer_review addresses the burning question: "Why are we here today?" cc: @AmeetSarpatwari @PORTAL_Research @JasonComander @MassEyeAndEar @HMSbioethics @PetrieFlom
#AWS2018 #DareToBeYou Random coincidence: I recently coauthored a paper with @PORTAL_Research & @US_FDA looking at the social media impact of FDA Drug Safety Communications related to Ambien (including the recommendation to lower dosing in women)
November 18, 2024 at 9:22 AM
#AWS2018 #DareToBeYou Random coincidence: I recently coauthored a paper with @PORTAL_Research & @US_FDA looking at the social media impact of FDA Drug Safety Communications related to Ambien (including the recommendation to lower dosing in women)
I'm moderating the first @PORTAL_Research #policyethx of the academic year, starting in 15 minutes in @HMSCountway. Looking forward to a conversation with @jessiegaeta & @andrewkolodny!
November 18, 2024 at 9:19 AM
I'm moderating the first @PORTAL_Research #policyethx of the academic year, starting in 15 minutes in @HMSCountway. Looking forward to a conversation with @jessiegaeta & @andrewkolodny!
First #policyethx of the year on the #opioidcrisis TOMORROW at @HMSCountway @HarvardMed!
Panelists: @jessiegaeta @BUMedicine @BHCHP & @andrewkolodny @BrandeisU @supportprop
Moderator: @DrSinhaEsq @PORTAL_Research @harvardmitCRS
Panelists: @jessiegaeta @BUMedicine @BHCHP & @andrewkolodny @BrandeisU @supportprop
Moderator: @DrSinhaEsq @PORTAL_Research @harvardmitCRS
November 18, 2024 at 9:19 AM
First #policyethx of the year on the #opioidcrisis TOMORROW at @HMSCountway @HarvardMed!
Panelists: @jessiegaeta @BUMedicine @BHCHP & @andrewkolodny @BrandeisU @supportprop
Moderator: @DrSinhaEsq @PORTAL_Research @harvardmitCRS
Panelists: @jessiegaeta @BUMedicine @BHCHP & @andrewkolodny @BrandeisU @supportprop
Moderator: @DrSinhaEsq @PORTAL_Research @harvardmitCRS
My @JAMA_current Viewpoint with @PORTAL_Research & @profmikecarrier is in print in the June 12th issue!
Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry:
Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry:
November 18, 2024 at 9:16 AM
My @JAMA_current Viewpoint with @PORTAL_Research & @profmikecarrier is in print in the June 12th issue!
Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry:
Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry:
Last minute tickets to @RedSox @Orioles at @fenwaypark with the @PORTAL_Research team! #FlyEaglesFly in enemy territory!
November 18, 2024 at 9:15 AM
Last minute tickets to @RedSox @Orioles at @fenwaypark with the @PORTAL_Research team! #FlyEaglesFly in enemy territory!
New in @PLOSMedicine with @akesselheim @PORTAL_Research: The next forum for unraveling FDA off-label marketing rules: State and federal legislatures #PLOSMedicine
November 18, 2024 at 9:14 AM
New in @PLOSMedicine with @akesselheim @PORTAL_Research: The next forum for unraveling FDA off-label marketing rules: State and federal legislatures #PLOSMedicine
My newest with @PORTAL_Research & @profmikecarrier in @JAMA_current: Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry
November 18, 2024 at 9:14 AM
My newest with @PORTAL_Research & @profmikecarrier in @JAMA_current: Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry